FDA — authorised 27 October 2003
- Marketing authorisation holder: GENENTECH
- Status: approved
🇺🇸 Hu1124 in United States
FDA authorised Hu1124 on 27 October 2003
Marketing authorisation
Hu1124 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Hu1124 approved in United States?
Yes. FDA authorised it on 27 October 2003.
Who is the marketing authorisation holder for Hu1124 in United States?
GENENTECH holds the US marketing authorisation.